Valuation: Becton, Dickinson and Company

Market Cap 49.21B 1,658B 43.9B 40.9B 37.22B 70.1B 4,739B 70.61B 494B 192B 2,419B 185B 181B 7,775B P/E 2026 *
34.8x
P/E 2027 * 19.4x
Enterprise Value 65.1B 2,193B 58.07B 54.1B 49.24B 92.72B 6,269B 93.41B 654B 254B 3,200B 244B 239B 10,285B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 3.2x
Free-Float
73.18%
Yield 2026 *
2.17%
Yield 2027 * 2.21%
1 day-2.45%
1 week-3.40%
Current month-2.45%
1 month-2.45%
3 months+15.03%
6 months+17.75%
Current year-1.49%
1 week 1.97
Extreme 1.97
2.06
1 month 1.93
Extreme 1.93
2.14
Current year 1.54
Extreme 1.54
2.36
1 year 1.54
Extreme 1.54
2.36
3 years 1.54
Extreme 1.54
2.36
5 years 1.54
Extreme 1.54
2.36
10 years 1.54
Extreme 1.54
2.36
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer 56 2023-12-03
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-2.45%-3.40% - - 48.16B
+2.67%-0.87%-25.63%+4.05% 169B
+1.84%-1.71%-9.96%+15.52% 110B
+3.55%+3.60%-23.02%+7.71% 106B
+1.19%-1.10%-48.90%-11.35% 73.87B
+1.90%+3.66%+4.02%+70.20% 58.98B
+1.73%+7.53%+10.68%+67.17% 51.28B
+2.19%-1.72%-6.68%-30.79% 48.16B
+1.67%-0.38%-16.50%+22.43% 40.84B
+1.80%+0.25%+29.60%+3.45% 32.21B
Average +1.63%+0.52%-9.60%+16.49% 76.69B
Weighted average by Cap. +1.95%+0.35%-15.54%+13.77%

Financials

2026 *2027 *
Net sales 19.28B 649B 17.2B 16.02B 14.58B 27.46B 1,856B 27.66B 194B 75.32B 948B 72.36B 70.8B 3,046B 19.74B 665B 17.61B 16.4B 14.93B 28.11B 1,901B 28.32B 198B 77.12B 970B 74.1B 72.5B 3,119B
Net income 1.44B 48.39B 1.28B 1.19B 1.09B 2.05B 138B 2.06B 14.43B 5.61B 70.62B 5.39B 5.28B 227B 2.34B 78.8B 2.09B 1.94B 1.77B 3.33B 225B 3.36B 23.49B 9.14B 115B 8.78B 8.59B 370B
Net Debt 15.88B 535B 14.17B 13.2B 12.01B 22.63B 1,530B 22.79B 160B 62.07B 781B 59.63B 58.35B 2,510B 13.95B 470B 12.45B 11.6B 10.55B 19.87B 1,344B 20.02B 140B 54.51B 686B 52.37B 51.24B 2,204B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-10-05 THB 1.990 -2.45% 59,402
26-10-02 THB 2.040 -0.97% 1,451
26-10-01 THB 2.060 +0.98% 14,944
26-09-30 THB 2.040 -0.97% 29,957
26-09-29 THB 2.060 0.00% 1,916
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
180.67USD
Average target price
196.50USD
Spread / Average Target
+8.76%

Quarterly revenue - Rate of surprise